Can a new strategy break the cycle of HIV care dropout?
NCT ID NCT06803316
First seen Aug 12, 2026 · Last updated Aug 13, 2026 · Updated 1 time
Summary
This study aims to develop a program to help people living with HIV in Zambia re-engage with care after they have missed appointments or stopped taking their medication. Many people cycle in and out of HIV care, and returning is a critical moment to prevent future lapses. Researchers will ask patients and healthcare providers about their needs and preferences to design a supportive strategy. The goal is to create a practical intervention that improves long-term retention and health outcomes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- A multicomponent reengagement strategy developed through patient and provider input, using human-centered design.
- What this could lead to
- If successful, this could lead to a practical program that helps people with HIV stay in care after returning, reducing treatment interruptions and improving long-term health.
- What could go wrong
- This is an early-stage study focused on developing the strategy, not testing its effectiveness. The intervention may not work in real-world settings or may not be feasible across all clinics.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV ANTIRETROVIRAL THERAPY (ART) ADHERENCE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre for Infectious Disease Research in Zambia (CIDRZ)
Lusaka, Lusaka Province, 10101, Zambia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A One-Two punch against cervical cancer: testing plus vaccination in HIV-Positive women
- Smart pill bottles and health coaches team up to tackle HIV in the deep south
- Can one Mega-Dose of an antifungal beat a deadly infection in AIDS patients?
- Can Long-Acting HIV shots outperform daily pills during lymphoma treatment?
- Immune-Boosting cocktail aims to free HIV patients from daily medication
- Pee test could revolutionize HIV treatment adherence